You are here: Industry Insights > COVID-19 vaccine

News List

Comirnaty® COVID-19 vaccine protects against multiple viral variants europeanpharmaceuticalreview
June 16, 2021
Laboratory study shows the blood sera of people vaccinated against COVID-19 with Comirnaty® can neutralise at least six viral variants including three variants of concern.
UK to donate 100 million surplus COVID-19 vaccine doses pharmatimes
June 16, 2021
The UK government will donate at least 100 million surplus COVID-19 vaccine doses within the next year, Prime Minister Boris Johnson announced on Friday.
Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia americanpharmaceuticalreview
June 16, 2021
Moderna Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceuticals company, announced an ...
FDA Takes Steps to Increase Availability of the Janssen COVID-19 Vaccine americanpharmaceuticalreview
June 16, 2021
Following careful review and deliberation, the U.S. FDA is taking important steps that will allow a critically needed supply of the Janssen (Johnson & Johnson) COVID-19 Vaccine to be made available.
Janssen COVID-19 Vaccine Shipment Made with Drug Substance from Emergent BioSolutions Fails QA americanpharmaceuticalreview
June 16, 2021
Health Canada has completed its quality review of the shipment of Janssen vaccines that are currently in quarantine. To protect the health and safety of Canadians in response to concerns regarding a drug substance produced at the Emergent BioSolutions ...
FDA authorises J&J Covid-19 vaccine substance made at Emergent’s plant pharmaceutical-technology
June 15, 2021
The US Food and Drug Administration (FDA) has approved, under the emergency use authorization (EUA), two batches of Johnson & Johnson (J&J) subsidiary Janssen’s Covid-19 vaccine drug substance produced at the Emergent BioSolutions’ plant in Baltimore, US.
Moderna’s new Covid-19 vaccine production facility gets EMA approval pharmaceutical-technology
June 15, 2021
Moderna has received the European Medicines Agency’s (EMA) committee for human medicines (CHMP) approval for a new production facility in Monts, France, to manufacture its Covid-19 vaccine.
Ocugen to seek full approval for Bharat Biotech’s Covaxin in the US pharmaceutical-technology
June 15, 2021
Ocugen has plans to seek full approval for Bharat Biotech’s Covid-19 vaccine candidate, Covaxin, in the US, after the Food and Drug Administration (FDA) declined to grant an Emergency Use Authorization (EUA).
Bharat Biotech shares full research data of COVAXIN expresspharma
June 15, 2021
Bharat Biotech has shared full data of all research studies of COVAXIN, its COVID-19 vaccine.
Janssen COVID-19 Vaccine can protect against variants of concern europeanpharmaceuticalreview
June 11, 2021
Trial shows the single-shot Janssen COVID-19 Vaccine generates robust immune responses against several COVID-19 variants.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page